We focus our research on the cancer epigenome and DNA methylation in particular. By integrating large-scale analyses with detailed candidate gene characterization we aim at identifying DNA methylation biomarkers with clinical impact.
The group is an associated member of the Centre for Excellence in Cancer Biomedicine.
Diseases we research
Topics we research
Epigenetic biomarkers for early detection and monitoring
Epigenetic master keys in cancer development
Analyzing the underlying biology and clinical potential of DNA methylation supernegative cancers